Technovalia is a privately owned early-stage Australian biotech company dedicated to the research and development of innovative vaccines and diagnostics. Technovalia, in partnership with several academic organisations and international companies is investing in the development of new technology platforms having the potential to significantly improve protection against a number of infectious diseases by producing safer, more stable, and more cost-effective vaccines and diagnostic tests. Contact: [email protected]